Global DNA Vaccines Market Growth 2025-2031

Global DNA Vaccines Market Growth 2025-2031

The global DNA Vaccines market size is predicted to grow from US$ 5261 million in 2025 to US$ 8344 million in 2031; it is expected to grow at a CAGR of 8.0% from 2025 to 2031.

The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.

Global direct-to-consumer genetic testing main players include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals and Plumbline Life Sciences, etc., totally accounting for about 50% of the market. North America is the largest market, with a share over 95%. As for the types of products, it can be divided into recombinant protein vaccine and gene-based vaccine. The most common product is recombinant protein, with a share over 95%. In terms of applications, it is widely used in human and animal. Human is the largest application, holding a share over 95%.

LP Information, Inc. (LPI) ' newest research report, the “DNA Vaccines Industry Forecast” looks at past sales and reviews total world DNA Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected DNA Vaccines sales for 2025 through 2031. With DNA Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DNA Vaccines industry.

This Insight Report provides a comprehensive analysis of the global DNA Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on DNA Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global DNA Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DNA Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DNA Vaccines.

This report presents a comprehensive overview, market shares, and growth opportunities of DNA Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Recombinant Protein Vaccine
Gene-Based Vaccine

Segmentation by Application:
Human
Animal

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences

Key Questions Addressed in this Report

What is the 10-year outlook for the global DNA Vaccines market?

What factors are driving DNA Vaccines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do DNA Vaccines market opportunities vary by end market size?

How does DNA Vaccines break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.